Aurora Cannabis Inc (ACB) stock
Close on Nov 11, 2026Market cap $297.69MP/E –Yield –
Aurora Cannabis Inc grew revenue 11.0% to C$320.59M over fiscal 2026. At the latest close the market valued the company at C$419.92M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026
Valuation
- Market cap
- C$419.92M
- P/E ratio
- –
- Price to sales
- 1.31
- Price to book
- 0.82
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$320.59M
- EPS, diluted
- -2.14 CAD
Trading
- Previous close
- $5.11
- Open
- $5.10
- Day's range
- $5.05 – $5.10
- Volume
- 699,158
- Average volume (20 days)
- 1,685,354
- Beta (5 years)
- 1.30
- RSI (14 days)
- 68.5
- Volatility (1 year)
- 60.1%
- Relative volume
- 0.49×
- WACC
- 11.4%
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ACB | S&P 500 | Difference | ACB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +12.5% | -2.4% | +14.9 pts | ||
| 3 months | +44.9% | -1.2% | +46.1 pts | ||
| Year to date | +19.7% | +12.3% | +7.4 pts | ||
| 1 year | +11.0% | +12.4% | −1.5 pts | ||
| 3 years | +7.4% | +78.8% | −71.4 pts | +2.4% | +21.4% |
| 5 years | -93.3% | +75.2% | −168.5 pts | -41.8% | +11.9% |
| 10 years | -97.2% | +311.1% | −408.3 pts | -30.0% | +15.2% |
Eight years at a glance
Fiscal years 2017 to 2026, CAD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Aurora Cannabis filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Aurora Cannabis
Medicinal Chemicals & Botanical Products
Aurora Cannabis Inc. engages in the cultivation, processing, and distribution of cannabis and related products. The company focuses primarily on its cannabis segment, with additional historical operations involving plant propagation. Its core product portfolio includes dried cannabis flower and cannabis extracts, supported by specialized production and agricultural facilities. Aurora supplies patients seeking medical cannabis, consumers in adult-use markets, and authorized commercial distributors across various jurisdictions.
Company profile, executives and historyAurora Cannabis stock: common questions
What is Aurora Cannabis's stock price?
ACB closed at $5.05 on Nov 11, 2026, down 1.17% on the day.
What is Aurora Cannabis's market cap?
Aurora Cannabis was worth $297.69M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ACB's P/E ratio?
Aurora Cannabis lost money over fiscal 2026 (diluted EPS -2.14 CAD), so it has no meaningful P/E ratio.
How much revenue does Aurora Cannabis make?
Aurora Cannabis reported revenue of C$320.59M for fiscal 2026, up 11.0% from a year earlier.
Does Aurora Cannabis pay a dividend?
No. Aurora Cannabis has not paid a cash dividend over the last twelve months.
How has ACB stock performed over the past year?
Including dividends, ACB returned +11.0% over the past year, against +12.4% for the S&P 500.
Who are Aurora Cannabis's competitors?
Companies most similar to Aurora Cannabis by business, industry and size include CGC, CRON, CRLBF, OGI, JUSH.
See a number that looks wrong?